https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL launches an innovative project for the advanced treatment of chronic and surgical wounds

17 de September de 2025

The Marqués de Valdecilla Research Institute (IDIVAL) is strengthening its commitment to healthcare innovation with a new project aimed at transforming the treatment of chronic and surgical wounds, one of the main challenges faced by healthcare systems worldwide. Through its DTEC-VAL technology development support program, IDIVAL funds initiatives with the potential to generate a real […]

Read more →

Verónica Vidal, the scientist researching how to make neurovascular interventions safer and more effective

16 de September de 2025

At the Valdecilla Health Research Institute (IDIVAL), innovation is written with proper names, and one of them is Verónica Vidal Sánchez. A PhD in Molecular Biology and Biomedicine, with over 20 scientific publications, two registered utility models, and a career marked by versatility, Vidal has been one of the seven researchers selected in the latest […]

Read more →

IDIVAL advances in the HRS4R Strategy with the update of its 2025-2029 Action Plan

11 de September de 2025

The Marqués de Valdecilla Health Research Institute (IDIVAL) continues to make progress in consolidating the European Human Resources Strategy for Researchers (HRS4R), a framework that promotes more transparent, inclusive working environments aligned with the principles of the European Charter for Researchers. As part of the update of the 2025-2029 Action Plan and the renewal of […]

Read more →

One Step Forward in Cognitive Assessment in Psychosis: The BAC App Validated in Spain

10 de September de 2025

People with psychosis often experience cognitive difficulties—such as problems with memory, attention, processing speed, or executive functions—that directly affect their daily lives, from maintaining employment to managing personal autonomy or social relationships. Despite their importance, assessing these abilities quickly and accurately in clinical practice is not always possible. In this context, a multicenter project led […]

Read more →

Carmen Cagigas, the surgeon who wants her patients to go home sooner and in better condition

9 de September de 2025

The NEXT-Val program drives a pioneering project on early discharge after robotic colorectal surgery The Valdecilla Health Research Institute (IDIVAL) has awarded seven young researchers in the latest edition of the NEXT-Val (NEXT generation Valdecilla) program, designed to promote translational research in Cantabria’s biosanitary field. Among the awardees is Carmen Cagigas, specialist in General and […]

Read more →

FECYT and Clarivate organize three free online training sessions on Web of Science

3 de September de 2025

The Spanish Foundation for Science and Technology (FECYT), in collaboration with Clarivate, will hold three new free online training sessions in Spanish this September, as part of the 2nd Online Training Cycle of the Web of Science database. These sessions are open to all institutions that are part of Spain’s national Web of Science license, […]

Read more →

The NEXT-Val Program Promotes Research on Immune Tolerance and Autoimmune Diseases

1 de September de 2025

The Valdecilla Institute for Health Research (IDIVAL) has recognized the work of seven young researchers in the latest edition of the NEXT-Val program (NEXT generation VALdecilla), an initiative that promotes translational research within Cantabria’s biomedical environment. Among the awardees is Daniel Álvarez, a postdoctoral researcher at IDIVAL, whose project addresses one of the body’s most […]

Read more →

A new study opens the door to improving treatment for rheumatoid arthritis with lung involvement

28 de August de 2025

A team of rheumatology specialists from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Health Research Institute (IDIVAL) has participated in a national multicenter study demonstrating the efficacy of baricitinib, a Janus kinase inhibitor, in patients with rheumatoid arthritis and associated pulmonary fibrosis. The study, published in the scientific journal Rheumatology […]

Read more →

Sánchez Escamilla drives translational research in CAR-T therapies thanks to the NEXT-Val grant

26 de August de 2025

Her project seeks to anticipate complications and improve the efficacy and safety of these therapies in hematology patients Within the framework of the Valdecilla Health Research Institute (IDIVAL), Dr. Miriam Sánchez Escamilla has been recognized as an emerging researcher under the NEXT-Val program (NEXT generation VALdecilla), an initiative that promotes translational research in Cantabria. The […]

Read more →

Juan Marta Enguita, the Neurologist Studying How to Halt Thromboinflammation in Stroke

20 de August de 2025

NEXT-Val Drives Research into New Predictive Models to Improve Prognosis in Severe Stroke Cases The Valdecilla Health Research Institute (IDIVAL) has awarded seven young researchers through the NEXT-Val program (NEXT generation VALdecilla), an initiative aimed at boosting translational research in the biomedical field in Cantabria. Among the awardees is Juan Marta Enguita, a neurologist specializing […]

Read more →